The present invention provides pharmaceutical agents comprising a dipeptidyl peptidase IV (DPPIV) inhibitor and a biguanide agent in combination, which enhance the effects of active circulating glucagon-like peptide-1 (GLP-1) and/or active circulating glucagon-like peptide-2 (GLP-2).

 
Web www.patentalert.com

< 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLES AS ESTROGENIC AGENTS

< Hormone composition

> Methods and compositions for the treatment of psychiatric conditions

> Quinoline derivatives as nk-2 and nk-3 receptor antagonists
~ 00259